Polymyalgia rheumatica and Interstitial lung disease

Summary:

Interstitial lung disease is found among people with Polymyalgia rheumatica, especially for people who are female, 60+ old.

The study analyzes which people have Interstitial lung disease with Polymyalgia rheumatica. It is created by eHealthMe based on reports of 35 people who have Polymyalgia rheumatica from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Polymyalgia rheumatica?

Polymyalgia rheumatica (pain in many muscles) is found to be associated with 381 drugs and 554 conditions by eHealthMe. Check the latest studies of Polymyalgia rheumatica.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,499 drugs and 1,839 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

On Jul, 15, 2026

35 people who have Polymyalgia Rheumatica and Interstitial Lung Disease are studied.

Would you have Interstitial lung disease when you have Polymyalgia rheumatica?

Gender of people who have Polymyalgia Rheumatica and experienced Interstitial Lung Disease *:

female: 68.75 %
male: 31.25 %

Age of people who have Polymyalgia Rheumatica and experienced Interstitial Lung Disease *:

Common co-existing conditions for these people *:

Breast Cancer: 10 people, 28.57%
Osteoporosis (bones weak and more likely to break): 8 people, 22.86%
High Blood Pressure: 7 people, 20.00%
Seasonal Allergy (allergic condition due to certain season): 7 people, 20.00%
Postmenopause: 7 people, 20.00%
Diabetes: 4 people, 11.43%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.43%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 11.43%
Urinary Tract Infection: 4 people, 11.43%
Gallstones (stone formation by bile component): 3 people, 8.57%

Common drugs taken by these people *:

Common symptoms for these people *:

Pneumonia: 12 people, 34.29%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 11 people, 31.43%
Urinary Tract Infection: 10 people, 28.57%
Spinal Compression Fracture (fracture due to spinal compression on bone): 8 people, 22.86%
C-Reactive Protein Increased: 8 people, 22.86%
Osteoporosis (bones weak and more likely to break): 8 people, 22.86%
Broken Bone: 7 people, 20.00%
Hypertensive Heart Disease: 7 people, 20.00%
Occult Blood Positive: 7 people, 20.00%
Mitral Valve Disease (disease of mitral valve of heart): 7 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Interstitial lung disease?

- Check whether Interstitial lung disease is associated with a drug or a condition

Related publications that referenced our studies

Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .
Thangakunam B, Christopher DJ, Mathews V, Srivastava A, "Mesenchymal stromal stem cell therapy in advanced interstitial lung disease-Anaphylaxis and short-term follow-up", Lung India: official organ of Indian Chest Society, 2015 Jan .
Kato, M., Oiso, N., Nozaki, Y., Inoue, A., Hosono, Y., Funauchi, M., ... & Kawada, A., "Antitumor necrosis factor alpha inhibitor‐induced dermatomyositis and interstitial lung disease with anti‐PL 12 autoantibody: Signs of antisynthetase syndrome", The Journal of dermatology, 2012 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Interstitial lung disease and Polymyalgia rheumatica, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.